Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in Prostate Cancer with Bone Metastasis
NCT00237159Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2002
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in prostate cancer (PCa), sponsored by Novartis. Started Oct 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00237159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237159.